GeneDx Holdings Corp.
Health
Performance
8.9
Risk
Sell
Buy
Curious about the Scores? Learn more.

GeneDx Holdings Corp. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

06.08.2026
Short-term strength kicking in. Early signs of life.
16.07.2026
Tiny rebound. Signs of life appear after deep struggle.
01.07.2026
Danger zone. Balance sheet’s flashing red across the board.
17.12.2025
Red alert. Risk levels out of control.
WGS
GeneDx Holdings Corp.
69.59
-0.46%
8.9
Sell
Buy
GeneDx Holdings Corp.

GeneDx Holdings Corp. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does GeneDx Holdings Corp. do? Business model and key facts

Get the full picture of GeneDx Holdings Corp.: what it builds, where it operates, and how it makes money.

GeneDx Holdings Corp. Profile

Sector: Healthcare

Industry: Medical - Healthcare Information Services

Employees (FY): 1300

GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.

shop
Company facts
Katherine A. Stueland
CEO
1300
Employees worldwide
shop
Performance
-34.26%
Last 12 months
-81.81%
Last 5 years
shop
Growth
$427.54M
Revenue year
$-21,021,000
Net income
shop
Valuation
$1.93B
Market Cap
-178.16
Price/Earnings Ratio

Stocks related to GeneDx Holdings Corp.

Selected based on industry alignment and relative market positioning.

PGNY
Progyny, Inc.
30.21
-3.70%
7.3
Sell
Buy
Progyny, Inc.
PRVA
Privia Health Group, Inc.
22.00
-8.18%
5.3
Sell
Buy
Privia Health Group, Inc.
DOCS
Doximity, Inc.
20.66
-4.48%
7.6
Sell
Buy
Doximity, Inc.
CERT
Certara, Inc.
8.13
+1.50%
8.8
Sell
Buy
Certara, Inc.
HSTM
HealthStream, Inc.
28.12
+0.39%
4.2
Sell
Buy
HealthStream, Inc.

Events and news impacting GeneDx Holdings Corp. stock

Earnings, coporate decisions and industry developments that can affect the share price.

GeneDx Holdings Corp. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.